Merck Sharp & Dohme recalls
Merck Sharp & Dohme has 5 recalls on record with the FDA and USDA, the earliest in 2021 and the latest reported on 31 Dec 2025. 2 are still ongoing. 2 were reported in the last 12 months. The most frequent reason is particulate matter.
Total recalls5since 2021
Last 12 months2reported
Class I120% of total
Ongoing2latest 31 Dec 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 20%Class II 4 80%Class III 0 0%
Why merck sharp & dohme is recalled
Product types
Brands
By year
Ongoing merck sharp & dohme recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Noxafil Powdermix (posaconazole) recalled by Merck Sharp & DohmeNoxafil | Merck Sharp & Dohme | Particulate Matter | Nationwide |
| Drug | CLASS II | Merck Emend (aprepitant) for oral suspension, 125 mg recalledEmend | Merck Sharp & Dohme | Particulate Matter | Nationwide |
All merck sharp & dohme recalls, newest first
5 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Noxafil Powdermix (posaconazole) recalled by Merck Sharp & DohmeNoxafil | Merck Sharp & Dohme | Particulate Matter | Nationwide |
| Drug | CLASS II | Merck Emend (aprepitant) for oral suspension, 125 mg recalledEmend | Merck Sharp & Dohme | Particulate Matter | Nationwide |
| Drug | CLASS II | Janumet (sitagliptin and metformin HCl) tablets recalledJanumet | Merck Sharp & Dohme | Particulate Matter | Nationwide |
| Drug | CLASS I | Cubicin (daptomycin for injection), 500 mg per vial recalled | Merck Sharp & Dohme | Particulate Matter | Nationwide |
| Drug | CLASS II | Zerbaxa (ceftolozane and tazobactam) per vial for injection recalledZerbaxa | Merck Sharp & Dohme | Sterility | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.